Summary PLD-repair following single dose and fractionated irradiation was studied in vivo using five human melanoma xenograft lines. Tumours given single graded radiation doses were excised immediately after or 24 h after the radiation exposure for assay of cell survival in vitro. All melanoma lines showed PLD-repair after single dose irradiation; the PLD-repair factors, i.e. the ratio of the Do values for tumours excised 24 h after and immediately after irradiation, ranged from 1.2±0.1 to 1.4±0. (1982a,b) showed data suggesting that differences in repair of potentially lethal damage (PLD) among cell lines in vitro may reflect differences in clinical radiocurability among the corresponding tumour types. If one or both of these postulates can be verified for individual tumours, they may lead to therapeutic strategies involving pretreatment in vitro testing of tumour radiocurability.
equal after immediate and delayed cell seeding, i.e. none of the melanoma lines showed significant PLD-repair after fractionated irradiation. The lack of PLD-repair after fractionated irradiation was possibly a consequence of radiation-induced recruitment of quiescent tumour cells into the cell cycle. Consequently, PLD-repair is probably not a major cause of failure in the radiation therapy of malignant melanoma when treated with 2.0 Gy fractions. Malaise (1981, 1985) have analysed published survival curves for human tumour cell lines and they found evidence that the cell surviving fraction at 2.0 Gy (SF2) for a given cell type was correlated to the 95% control dose for tumours of corresponding histology. Deacon et al. (1984) carried out a similar analysis and demonstrated a clear relationship between the initial slope of cell survival curves and the clinical radioresponsiveness of tumours by grouping cell lines and tumours according to histological category. On the other hand, Weichselbaum et al. (1982a,b) showed data suggesting that differences in repair of potentially lethal damage (PLD) among cell lines in vitro may reflect differences in clinical radiocurability among the corresponding tumour types. If one or both of these postulates can be verified for individual tumours, they may lead to therapeutic strategies involving pretreatment in vitro testing of tumour radiocurability.
The radiation biology of human melanoma xenografts grown in congenitally athymic mice is currently being studied in our institute. In a previous work involving five different lines, a significant correlation was found between the radioresponsiveness of the melanomas in vivo (2.0 Gy fractions) and the initial slope of the cell survival curves in vitro (Rofstad & Brustad, 1987) . However, the melanomas were not so radioresponsive in vivo as the SF2-values alone predicted, suggesting that other factors, e.g. regrowth between fractions and/or PLD-repair, also were of importance. The purpose of the study reported here was to investigate whether the radioresponsiveness of the melanomas is significantly influenced by PLD-repair.
Materials and methods

Mice and tumours
Female BALB/c/nu/nu/BOM mice, bred at the animal department of our institute, were used. They were kept under specific pathogen-free conditions. hole in the cranial end through which they could breathe freely. A piston in the tail end positioned the mice firmly in the tubes. A hole was cut in each tube through which the tumours protruded. To ensure uniform doses throughout the tumour volumes, the tumours were exposed to irradiation by two opposing treatment fields through each of which 50% of the dose was delivered.
The tumours were irradiated when they attained a volume within the range 300-500 mm3. Callipers were used to measure tumour volumes. Two perpendicular diameters (length and width) were recorded, and the volumes were calculated as V= lab2 where a and b are the longest and the shortest diameter, respectively.
Colony assay
The fraction of surviving cells in the tumours after irradiation in vivo was measured in vitro using a soft agar colony assay similar to that developed by Courtenay and Mills (1978) . Single cell suspensions were prepared from the tumours using a standardised mechanical procedure; the tumours were put into plastic bags with 20 ml culture medium (Ham's F-12 medium with 20% fetal calf serum, penicillin (250 mg l') and streptomycin (50 mg 11), all from Gibco Limited, Paisley, UK), and disaggregated for 30 s with a stomacher (Lab-Blender 80, Seward Laboratory, London, UK). The resulting suspensions were filtered through 30 Am nylon mesh. The cell concentrations were determined using a haemocytometer. The number of host cells in the tumours, especially macrophages, tended to be higher after fractionated than after single dose irradiation. The host cells could usually be distinguished easily from the melanoma cells on the basis of size. Melanoma cells having an intact and smooth outline with a bright halo were scored as morphologically intact and counted. The cell yield was calculated as the total number of morphologically intact melanoma cells divided by the tumour volume as measured immediately before the first radiation exposure.
The soft agar was prepared from powdered agar (Bacto agar, Difco, Detroit, MI, USA) and culture medium (see above). Erythrocytes from August rats and melanoma cells were added as described previously (Rofstad, 1981) . Aliquots of I ml of soft agar with the appropriate number of melanoma cells were seeded in plastic tubes (Falcon 2057 tubes, Becton Dickinson, Oxnard, CA, USA). The cells were then incubated at 37°C for 3-4 weeks (EE, EF) 4-5 weeks (MF, VN) or 5-6 weeks (GE) in an atmosphere of 5% 02, 5% Co2 and 90% N2. Culture medium (2 ml) was added on the top of the agar 5 days after seeding and then changed weekly. A stereomicroscope was used to count colonies. The dense colonies formed by the melanoma cells could be distinguished easily from the loose colonies formed by the macrophages. Melanoma cells giving rise to colonies larger than 50 cells were scored as surviving. The plating efficiency of the morphologically intact cells from unirradiated tumours was 10-20% (GE), 15-35% (EE, MF, VN) and 30-60% (EF). The fraction of surviving cells in an irradiated tumour was calculated from the mean number of colonies in four tubes with cells from that tumour and four tubes with cells from an unirradiated tumour, and the number of morphologically intact cells seeded and the cell yield for the two tumours, i.e. the surviving fractions were measured relative to the number of clonogenic cells in the tumours immediately before the first radiation exposure.
Data analysis
Survival curves were fitted to the data by least-squares linear regression analysis. The analysis was based on surviving fractions measured for individual tumours. Only data points at doses judged to be beyond the shoulder region of the survival curves (asphyxiated mice) and data points at doses eliminating the oxic cells (air-breathing mice) were included in the analysis.
Results
Cell survival curves for tumours given single dose irradiation are illustrated in Figure 1 and the corresponding survival curve parameters are presented in Table I irradiation. The points represent the means of four to six individual tumours studied separately and the bars represent s.e.m. The dashed survival curves are redrawn from a previous publication (Rofstad & Brustad, 1981) imately equal for all three experimental conditions (Table I) and the cell surviving fractions were similar for tumours excised immediately after or 24 h after irradiation in airbreathing mice (Figure 2 ). u.uuul Discussion PLD-repair following single dose irradiation has been studied by several research groups by maintaining cultured cells in a quiescent phase in vitro and experimental tumours in an imperturbed state in vivo for a few hours between the radiation exposure and assay of cell survival (Bertrand & Deen, 1980; Iliakis, 1988) . Human tumour cell lines have thus been found to differ considerably in PLD-repair capacity; melanomas, for example, seem to show a particularly high capacity (Weichselbaum & Little, 1982; Weichselbaum, 1984) . Significant PLD-repair has also been demonstrated for several rodent tumour lines in vivo, grown in ascitic as well as solid forms (Bertrand & Deen, 1980; Weichselbaum & Little, 1982) . Moreover, human tumour xenografts, mainly melanomas and colon adenocarcinomas, have been found to show PLD-repair factors in vivo which are at least as high as those observed in rodent tumours (Guichard et al., 1984; Rofstad, 1986) . The PLD-repair factors found after single dose irradiation of the melanoma xenograft lines studied here were comparable to those reported for many other in vitro and in vivo tumour models. Interestingly, all melanoma lines lost their PLD-repair capacity when seven fractions of 2.0Gy were given before the test doses. Detailed studies of PLD-repair following fractionated irradiation in vivo have not been reported for other experimental tumours so far. In contrast to the present observation, tumour cells cultured in vitro have been found to maintain their PLD-repair capacity after fractionated irradiation (Weichselbaum, 1984) .
Lack of PLD-repair capacity in the melanomas after fractionated irradiation was possibly a consequence of radiationinduced changes in their proliferative status. Several observations suggest that PLD-repair occurs primarily in quiescent tumour cells. Firstly, PLD-repair in vitro is usually observed only in proliferation-inhibited cell cultures, induced by confluence, metabolic inhibitors, low serum concentrations or low temperature (Weichselbaum & Little, 1982; Guichard et al., 1984) . Secondly, large solid tumours express more PLDrepair than small ones (Hahn et al., 1974; Tubiana et al., 1977) and old ascitic tumours more than young ones (Little et al., 1973) . Thirdly, slowly growing tumours tend to show higher PLD-repair factors than rapidly growing tumours of the same size (Guichard et al., 1984) . Finally, PLD-repair was not observed in the RIF-I tumour line after single dose irradiation, a line possessing a high growth fraction and a very low fraction of radiobiologically hypoxic cells (Rasey & Nelson, 1983) . One possible explanation why PLD-repair was not observed after fractionated irradiation of the melanomas may therefore be that the fractionated irradiation caused significant recruitment of quiescent tumour cells into the cell cycle. This hypothesis is indeed supported by experimental data on the melanomas. Thus, flow cytometric and PLMstudies of the cell proliferation kinetics in the EE melanoma have shown that the cell cycle time is shortened and the growth fraction considerably increased after single dose irradiation (Rofstad et al., 1980) . Moreover, all melanoma lines have been found to show significant repopulation (Rofstad & Brustad, 1987) and extensive reoxygenation (Rofstad, 1989) during fractionated irradiation (2.0 Gy fractions).
If human melanoma xenografts are representative models for melanomas in humans, the present data may have some implications for the choice of strategy in clinical radiation therapy of malignant melanoma. Firstly, malignant melanoma is treated with large radiation doses per fraction in many countries. The single dose data in Figure 1 may therefore have clinical relevance, suggesting that PLD-repair may occur and hence decrease the clinical radioresponsiveness of malignant melanoma when large fractional doses are given. Secondly, the data in Figure 2 indicate that PLDrepair does not have a significant influence on the radioresponsiveness of the melanoma xenografts when treated with 2.0 Gy fractions. Moreover, previous studies have shown that the radioresponsiveness of the xenografts (2.0 Gy fractions) is correlated to the initial slope of the corresponding radiation cell survival curves in vitro (Rofstad & Brustad, 1987) . Thus, in vitro predictive assays for clinical radiocurability of malignant melanoma should probably be based on SF2 values rather than PLD-repair factors when conventional fractionation regimens are prescribed. Moreover, clinical trials aimed at studying chemical modification of radiation response should probably involve agents that modify the shoulder of the cell survival curve, rather than agents that inhibit PLDrepair.
